Group structure
11 companies in 3 countries
Loading your page…
Loading your page…
11 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 29
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BISMUTH SUBSALICYLATE CAPLETS262 mg · Tablet | Bismuth subsalicylate | Canada | Marketed | 2010 |
| BISMUTH SUBSALICYLATE SUSPENSION17.5 mg / ml · Suspension | Bismuth subsalicylate | Canada | Marketed | 2008 |
| COUGH & CHEST CONGESTION LIQUID100 mg / 5 ml · Solution | Guaifenesin | Canada | Authorised | |
| Esketamine IDD 25 mg/ml, oplossing voor injectie/infusieOplossing voor injectie of infusie | Esketamine | Netherlands | Authorised | 2019 |
| Esketamine IDD 5 mg/ml, oplossing voor injectie/infusieOplossing voor injectie of infusie | Esketamine | Netherlands | Authorised | 2019 |
| EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION35 mg / ml · Suspension | Bismuth subsalicylate | Canada | Marketed | 2010 |
| FOAMCOAT80mg; 20mg · Tablet, chewable | Aluminum hydroxide, Trisilicate | United States | Not marketed | 1987 |
| GAS RELIEF TABLETS125 mg · Tablet (Chewable) | Dimethicone | Canada | Marketed | 2010 |
| GUAIFENESIN1.2gm | 600mg · Tablet, extended release | Guaifenesin | United States | Marketed | 2011 |
| IBUPROFEN100mg/5ml · Suspension | Ibuprofen | United States | Marketed | 1998 |
| STOMACH RELIEF CHEWABLE TABLETS262 mg + 350 mg · Tablet (Chewable) | Bismuth subsalicylate, Carbonate | Canada | Marketed | 2013 |
| LIGNOCAIN 2 % JELLY | Lidocaine | Saudi Arabia | Authorised | |
| LIGNOCAIN 2 % JELLY | Lidocaine | Saudi Arabia | Authorised | |
| SANCUSO 34.3 mg transdermal patch | Granisetron | Saudi Arabia | Authorised | |
| ACETAMINOPHEN TAB EXTRA STRENGTH 500MG500 mg / tab · Tablet | Paracetamol | Canada | Cancelled | 1984 |
| ACETYLSALICYLIC ACID 325MG TAB325 mg / tab · Tablet | Acetylsalicylic acid | Canada | Cancelled | 1951 |
| ACIDEX TC ORAL SUSPENSION600 mg / 5 ml + 300 mg / 5 ml · Suspension | Aluminum hydroxide, Hydroxide | Canada | Cancelled | |
| ASA TAB 325MG325 mg / tab · Tablet | Acetylsalicylic acid | Canada | Cancelled | 1951 |
| CALAMINE LOTION8 % + 8 % · Lotion | Calamine, Zinc oxide | Canada | Cancelled | 1995 |
| CHILDREN'S ACETAMINOPHEN EASYMELT TABLETS80 mg · Tablet | Paracetamol | Canada | Cancelled | |
| COD LIVER OIL W ADDED VIT A&D1800 unit / g + 200 unit / g · Liquid | Vitamin a, Vitamin d | Canada | Cancelled | 1978 |
| COUGH CONTROL10 mg / 5 ml + 100 mg / 5 ml · Solution | Dextromethorphan, Guaifenesin | Canada | Cancelled | |
| COUGH CONTROL EXTRA STRENGTH20 mg / 10 ml + 400 mg / 10 ml · Syrup | Dextromethorphan, Guaifenesin | Canada | Cancelled | |
| JUNIOR'S ACETAMINOPHEN EASYMELT TABLETS160 mg · Tablet (Chewable) | Paracetamol | Canada | Cancelled | |
| KAOLIN AND PECTIN SUSP200 mg / ml + 10 mg / ml · Suspension | Kaolin, Pectin | Canada | Cancelled | 1963 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 21 | 6 | 15 | CompaniesAll medicines |
| Saudi Arabia | 3 | 3 | 0 | CompaniesAll medicines |
| United States | 3 | 3 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of France, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.